It’s called convalescent plasma, which is taken from recovered COVID patients.
In Monday’s Max Minute, CBS2’s Dr. Max Gomez explains what the treatment entails and why many experts are unsure about its safety and efficacy.
- Tri-State Coronavirus Travel Advisory Quarantine List
- Resources, Hotlines, Unemployment & Covering Bills
- Remote Learning Tools For Parents Teaching At Home
- CBS2’s Dr. Max Answers Your Health Questions
- What To Do If Someone Isn’t Social Distancing Or Wearing A Mask?
- Expert: Parents Be Mindful Of Children’s Stress After Months Of Isolation
- Chopper 2 Over Empty NYC Streets, Landmarks
- Complete Coronavirus Coverage
Plasma is the liquid part of blood. The hope with convalescent plasma is that infusions of antibody-rich plasma can be injected into sick patients, binding or neutralizing the coronavirus so the patients can recover.
It’s been given to more than 70,000 COVID-19 patients, with mixed results.
Just last week, the FDA declined to issue authorization. Renowned scientists, such as Dr. Francis Collins, director of the National Institute of Health, said there just wasn’t enough evidence to warrant it.
The new emergency use authorization claims convalescent plasma reduced mortality by 35 percent. It appears to be based on a 35,000 patient trial from the Mayo Clinic. However, many public health experts said that was not a placebo controlled double-blind study and patients may have been getting a number of other medications that could account for the results.
CORONAVIRUS: NY Health Dept. | NY Call 1-(888)-364-3065 | NYC Health Dept. | NYC Call 311, Text COVID to 692692 | NJ COVID-19 Info Hub | NJ Call 1-(800)-222-1222 or 211, Text NJCOVID to 898211 | CT Health Dept. | CT Call 211 | Centers for Disease Control and Prevention
In any case, the benefit was only if the plasma was given within three days of the onset of symptoms.
It’s unclear whether the emergency use authorization will result in a meaningful expansion in access to convalescent plasma therapy.
Tens of thousands of COVID-19 patients have already received the treatment through the FDA’s expanded access program, and the supply is limited to the number of recovered patients who donate plasma.
Dr. Gomez said the plasma may help some patients recover, but it is not a breakthrough therapy.
You can get the latest news, sports and weather on our brand new CBS New York app. Download here.